[ad_1]
The vaccine, developed by AstraZeneca and the University of Oxford, could also be around 95 percent effective, according to The Sunday Times.
The news was announced by AstraZeneca CEO Pascal Soriot, who also said that scientists had recently found “the winning formula to make the vaccine as effective as other vaccines.”
In this way, this vaccine will also be able to protect 95 percent of patients, he said.
In previous experiments, the vaccine showed much lower efficacy than the vaccine developed by Pfizer / BioNTech and Moderna, but last month it was already close to 90 percent effective, which is believed to have increased again, although this is not yet known. . how.
The use of the vaccine is expected to be approved by UK authorities next week and then approved in India.
One of the advantages of AstraZeneca / Oxford is that it is much easier to store and transport.
This vaccine can be stored at temperatures between 2 and 8 degrees,
in contrast to Moderna -20 degrees and the Pfizer / BioNTech vaccines at -70 degrees.
It will also be much cheaper to obtain as it will be delivered to customers at a cost of production.
This is estimated to cost just four dollars a dose of the vaccine,
whereas a piece of the Pfizer / BioNTech vaccine costs twenty and a modern one costs twenty five dollars.
[ad_2]
